R&D center |
The R&D center is located in the National Technology Park of Jiangnan University, Wuxi. Currently, it has four R&D platforms, including MDI, nasal spray, nebulizer, and DPI, covering an area of 3000 m² for research and development of new delivery technologies and formulations. CF’s strategy is to focus on: • Developing new formulations for existing and new substances • Developing new delivery systems for existing and new active pharmaceutical ingredients in respiratory medicine • Increasing its intellectual property • Obtaining regulatory approvals for its products • Teaming-up with independent research teams to develop new products |
Therapeutic areas
It is estimated that more than 300 million people worldwide suffer from chronic respiratory diseases. CF is proud that it focuses on the therapeutic area of respiratory medicine including treatments for asthma, COPD, and rhinitis. |
|||||||||
|
|||||||||